Skip to main content

737 max

2 articles found

BA: Recovery Takes Flight as Defense Demand Soars

Boeing (BA) shares trade at $229.35 — a testament to the market's conviction that the aerospace giant's multi-year turnaround is finally gaining momentum. Up 78% from its 52-week low of $128.88, the stock reflects a company that delivered $89.5 billion in 2025 revenue while still posting negative free cash flow and carrying one of the most leveraged balance sheets in the S&P 500. The turnaround narrative centers on 737 MAX production ramps, a massive order backlog, and the Q4 2025 surprise — a $9.1 billion non-operating gain that pushed net income to $8.2 billion for the quarter alone. Strip out the one-time gain and Boeing's operating business still lost $815 million in Q4, but the trajectory is unmistakably improving. Now, the Iran military conflict adds a new dimension. Boeing's defense and space division stands to benefit from accelerating U.S. defense spending, while defense stocks broadly rally on geopolitical uncertainty. For Boeing investors, the question is whether defense tailwinds can compound the commercial aviation recovery — or whether the balance sheet's roughly $43 billion in net debt makes this rally too fragile to trust.

BABoeingdefense stocks

BA Analysis: Boeing's $182 Billion Turnaround Bet

Boeing (NYSE: BA) trades at $232.03 per share, giving the aerospace and defense giant a market capitalization of $182.2 billion. The stock has nearly doubled from its 52-week low of $128.88, sitting just 9% below its $254.35 high — a remarkable recovery for a company that posted a $5.4 billion operating loss in fiscal 2025 and burned through $1.9 billion in free cash flow. The bull case rests on Boeing's irreplaceable duopoly position with Airbus in commercial aviation, a $59.4 billion deferred revenue backlog representing years of aircraft orders, and early signs of production recovery. The bear case is equally compelling: $54.1 billion in total debt, razor-thin equity of just $5.5 billion after three consecutive quarters of negative book value, ongoing Starliner embarrassments, and an operating business that has not turned a consistent profit since the 737 MAX crisis began in 2019. With trailing earnings of just $2.48 per share — inflated by a $9.1 billion non-operational gain in Q4 2025 — and a P/E ratio of 93.6x, Boeing is priced for a turnaround that has yet to materialize in the operating numbers. This analysis examines whether the stock's premium reflects justified optimism or dangerous complacency.

Boeing stock analysisBA stockBoeing turnaround